Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
IMPACT Therapeutics, Inc (HKG:7630)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Alerts
Compare
14.07
+0.14 (1.01%)
Sep 30, 2026, 4:08 PM HKT
Overview
Financials
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
IMPACT Therapeutics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Cash & Equivalents
820.55
258.53
230.12
Trading Asset Securities
9.89
-
110.07
Cash & Short-Term Investments
1,065
258.53
340.19
Cash Growth
-
-24.00%
-
Receivables
38.03
7.44
-
Inventory
24.88
26.98
4.35
Restricted Cash
0
0
0
Other Current Assets
16.55
30.02
29.84
Total Current Assets
1,145
322.98
374.39
Property, Plant & Equipment
4.96
5.96
9.19
Other Intangible Assets
3.99
4.67
3.5
Other Long-Term Assets
1
0.92
1.82
Total Assets
1,155
334.52
388.89
Liabilities
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Accounts Payable
57.3
49.86
67.82
Accrued Expenses
-
9.25
10.06
Current Portion of Leases
3.48
3.66
1.8
Current Income Taxes Payable
-
1.01
0.74
Current Unearned Revenue
-
25.04
2.81
Other Current Liabilities
81.18
15.98
6.31
Total Current Liabilities
141.95
104.79
89.53
Long-Term Leases
0.75
1.78
4.99
Long-Term Unearned Revenue
-
171.7
91.54
Other Long-Term Liabilities
236.31
1,014
947.13
Total Liabilities
379.01
1,292
1,133
Shareholders' Equity
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Common Stock
282.46
234.19
214.87
Additional Paid-In Capital
1,859
927.65
1,141
Retained Earnings
-1,363
-1,272
-1,246
Comprehensive Income & Other
-3.09
-847.8
-853.78
Shareholders' Equity
775.77
-957.89
-744.29
Total Liabilities & Equity
1,155
334.52
388.89
Additional Metrics
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Total Debt
4.23
5.44
6.79
Net Cash (Debt)
1,061
253.1
333.41
Net Cash Growth
-
-24.09%
-
Net Cash Per Share
4.42
1.11
1.66
Filing Date Shares Outstanding
282.46
234.19
200.51
Total Common Shares Outstanding
282.46
234.19
200.51
Working Capital
1,003
218.19
284.86
Book Value Per Share
2.75
-4.09
-3.71
Tangible Book Value
771.78
-962.57
-747.79
Tangible Book Value Per Share
2.73
-4.11
-3.73
Machinery
-
1.31
1.25
Leasehold Improvements
-
5.77
5.75